{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T08:52:45Z","timestamp":1793523165883,"version":"4.5.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T00:00:00Z","timestamp":1585872000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T00:00:00Z","timestamp":1585872000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"crossref","award":["K08CA21531"],"award-info":[{"award-number":["K08CA21531"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006920","name":"University of Pennsylvania","doi-asserted-by":"publisher","award":["ITMAT MHB"],"award-info":[{"award-number":["ITMAT MHB"]}],"id":[{"id":"10.13039\/100006920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","award":["1017184"],"award-info":[{"award-number":["1017184"]}],"id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s10549-020-05612-7","type":"journal-article","created":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T12:03:57Z","timestamp":1585915437000},"page":"181-188","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Frequency of radiation-induced malignancies post-adjuvant radiotherapy for breast cancer in patients with Li-Fraumeni syndrome"],"prefix":"10.1007","volume":"181","author":[{"given":"Anh N.","family":"Le","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Harton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heena","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacquelyn","family":"Powers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Zelley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela R.","family":"Bradbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine L.","family":"Nathanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payal D.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Doucette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary M.","family":"Freedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Domchek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne P.","family":"MacFarland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8192-4202","authenticated-orcid":false,"given":"Kara N.","family":"Maxwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,3]]},"reference":[{"issue":"23","key":"5612_CR1","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1002\/cncr.30248","volume":"122","author":"PL Mai","year":"2016","unstructured":"Mai PL, Best AF, Peters JA, DeCastro RM, Khincha PP, Loud JT, Bremer RC, Rosenberg PS, Savage SA (2016) Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort. Cancer 122(23):3673\u20133681","journal-title":"Cancer"},{"issue":"1","key":"5612_CR2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/CCO.0000000000000423","volume":"30","author":"A Amadou","year":"2018","unstructured":"Amadou A, Waddington Achatz MI, Hainaut P (2018) Revisiting tumor patterns and penetrance in germline TP53 mutation carriers: temporal phases of Li-Fraumeni syndrome. Curr Opin Oncol 30(1):23\u201329. https:\/\/doi.org\/10.1097\/CCO.0000000000000423","journal-title":"Curr Opin Oncol"},{"issue":"21","key":"5612_CR3","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1200\/JCO.2014.59.5728","volume":"33","author":"G Bougeard","year":"2015","unstructured":"Bougeard G, Renaux-Petel M, Flaman J-M, Charbonnier C, Fermey P, Belotti M, Gauthier-Villars M, Stoppa-Lyonnet D, Consolino E, Brugieres L, Caron O, Benusiglio PR, Bressac-de Paillerets B, Bonadona V, Bonaiti-Pellie C, Tinat J, Baert-Desurmont S, Frebourg T (2015) Revisiting Li-Fraumeni syndrome from TP53 mutation carriers. J Clin Oncol 33(21):2345\u20132352","journal-title":"J Clin Oncol"},{"issue":"11","key":"5612_CR4","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1158\/1078-0432.CCR-17-0408","volume":"23","author":"CP Kratz","year":"2017","unstructured":"Kratz CP, Achatz MI, Brugieres L, Frebourg T, Garber JE, Greer MC, Hansford JR, Janeway KA, Kohlmann WK, McGee R, Mullighan CG, Onel K, Pajtler KW, Pfister SM, Savage SA, Schiffman JD, Schneider KA, Strong LC, Evans DGR, Wasserman JD, Villani A, Malkin D (2017) Cancer screening recommendations for individuals with Li-Fraumeni syndrome. Clin Cancer Res 23(11):e38\u2013e45. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-0408","journal-title":"Clin Cancer Res"},{"issue":"3","key":"5612_CR5","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.acra.2009.10.014","volume":"17","author":"AAK Abdel Razek","year":"2010","unstructured":"Abdel Razek AAK, Gaballa G, Denewer A, Tawakol I (2010) Diffusion weighted MR imaging of the breast. Acad Radiol 17(3):382\u2013386","journal-title":"Acad Radiol"},{"key":"5612_CR6","unstructured":"Network NCC (2019) Breast Cancer (Version 2.2019). https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast.pdf. Accessed 18 July 2019"},{"issue":"2","key":"5612_CR7","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s10549-017-4531-y","volume":"167","author":"K Schon","year":"2018","unstructured":"Schon K, Tischkowitz M (2018) Clinical implications of germline mutations in breast cancer: TP53. Breast Cancer Res Treat 167(2):417\u2013423. https:\/\/doi.org\/10.1007\/s10549-017-4531-y","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"5612_CR8","first-page":"983","volume":"36","author":"J De Moura","year":"2010","unstructured":"De Moura J, Kavalec FL, Doghman M, Rosati R, Custodio G, Lalli E, Cavallari GMD, Santa Maria J, Figueiredo BC (2010) Heterozygous TP53stop146\/R72P fibroblasts from a Li-Fraumeni syndrome patient with impaired response to DNA damage. Int J Oncol 36(4):983\u2013990","journal-title":"Int J Oncol"},{"key":"5612_CR9","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.ejca.2018.06.011","volume":"101","author":"E Kasper","year":"2018","unstructured":"Kasper E, Angot E, Colasse E, Nicol L, Sabourin J-C, Adriouch S, Lacoume Y, Charbonnier C, Raad S, Frebourg T, Flaman J-M, Bougeard G (2018) Contribution of genotoxic anticancer treatments to the development of multiple primary tumours in the context of germline TP53 mutations. Eur J Cancer 101:254\u2013262","journal-title":"Eur J Cancer"},{"issue":"1","key":"5612_CR10","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1053\/j.gastro.2018.09.036","volume":"156","author":"SP MacFarland","year":"2019","unstructured":"MacFarland SP, Zelley K, Long JM, McKenna D, Mamula P, Domchek SM, Nathanson KL, Brodeur GM, Rustgi AK, Katona BW, Maxwell KN (2019) Earlier colorectal cancer screening may be necessary in patients with Li-Fraumeni syndrome. Gastroenterology 156(1):273\u2013274. https:\/\/doi.org\/10.1053\/j.gastro.2018.09.036","journal-title":"Gastroenterology"},{"key":"5612_CR11","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program released April 2019, based on the November 2018 submissions"},{"issue":"4","key":"5612_CR12","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1002\/cncr.26377","volume":"118","author":"A Melhem-Bertrandt","year":"2012","unstructured":"Melhem-Bertrandt A, Bojadzieva J, Ready KJ, Obeid E, Liu DD, Gutierrez-Barrera AM, Litton JK, Olopade OI, Hortobagyi GN, Strong LC, Arun BK (2012) Early onset HER2-positive breast cancer is associated with germline TP53 mutations. Cancer 118(4):908\u2013913","journal-title":"Cancer"},{"issue":"4","key":"5612_CR13","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/ijc.1021","volume":"96","author":"JM Limacher","year":"2001","unstructured":"Limacher JM, Frebourg T, Natarajan-Ame S, Bergerat JP (2001) Two metachronous tumors in the radiotherapy fields of a patient with Li-Fraumeni syndrome. Int J Cancer 96(4):238\u2013242","journal-title":"Int J Cancer"},{"issue":"7","key":"5612_CR14","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.clon.2007.05.001","volume":"19","author":"A Salmon","year":"2007","unstructured":"Salmon A, Amikam D, Sodha N, Davidson S, Basel-Vanagaite L, Eeles RA, Abeliovich D, Peretz T (2007) Rapid development of post-radiotherapy sarcoma and breast cancer in a patient with a novel germline 'de-novo' TP53 mutation. Clin Oncol (R Coll Radiol) 19(7):490\u2013493","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"5612_CR15","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/1748-717X-5-104","volume":"5","author":"S Heymann","year":"2010","unstructured":"Heymann S, Delaloge S, Rahal A, Caron O, Frebourg T, Barreau L, Pachet C, Mathieu M-C, Marsiglia H, Bourgier C (2010) Radio-induced malignancies after breast cancer postoperative radiotherapy in patients with Li-Fraumeni syndrome. Radiat Oncol 5:104","journal-title":"Radiat Oncol"},{"issue":"4","key":"5612_CR16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1136\/jmg.2005.036319","volume":"43","author":"DGR Evans","year":"2006","unstructured":"Evans DGR, Birch JM, Ramsden RT, Sharif S, Baser ME (2006) Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromes. J Med Genet 43(4):289\u2013294","journal-title":"J Med Genet"},{"issue":"34","key":"5612_CR17","doi-asserted-by":"publisher","first-page":"4621","DOI":"10.1038\/sj.onc.1204621","volume":"20","author":"JM Birch","year":"2001","unstructured":"Birch JM, Alston RD, McNally RJ, Evans DG, Kelsey AM, Harris M, Eden OB, Varley JM (2001) Relative frequency and morphology of cancers in carriers of germline TP53 mutations. Oncogene 20(34):4621\u20134628","journal-title":"Oncogene"},{"issue":"1","key":"5612_CR18","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1245\/s10434-016-5558-8","volume":"24","author":"A Recht","year":"2017","unstructured":"Recht A, Comen EA, Fine RE, Fleming GF, Hardenbergh PH, Ho AY, Hudis CA, Hwang ES, Kirshner JJ, Morrow M, Salerno KE, SledgeSolin GWLJ, Spears PA, Whelan TJ, Somerfield MR, Edge SB (2017) Postmastectomy radiotherapy: an American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology focused guideline update. Ann Surg Oncol 24(1):38\u201351","journal-title":"Ann Surg Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-020-05612-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-020-05612-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-020-05612-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T19:22:58Z","timestamp":1617391378000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-020-05612-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,3]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["5612"],"URL":"https:\/\/doi.org\/10.1007\/s10549-020-05612-7","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,3]]},"assertion":[{"value":"4 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Author SMD has received honoraria from Clovis, Bristol-Myers Squibb, and AstraZeneca. Author AB has an advisory role at AstraZeneca and Merck and has received research fund not related to this manuscript from AstraZeneca and Merck. All other authors declare that they have no potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This single-institution human subjects' retrospective chart review is qualified for exempt status and does not require informed consent or waiver of consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}